Review of Lung Cancer Quality Performance Indicators: consultation

A consultation on the revised Lung Cancer Quality Performance Indicators (QPIs), which were revised following a formal review.


8. Areas for Future Consideration

The Lung Cancer QPI Groups have not been able to identify sufficient evidence, or determine appropriate measurability specifications, to address all areas felt to be of key importance in the treatment of lung cancer, and therefore in improving the quality of care for patients affected by lung cancer.

The following areas for future consideration have been raised across the lifetime of the Lung Cancer QPIs.

  • Clinical management of patients with mesothelioma.
  • CT scan undertaken prior to first respiratory physician consultation.

Contact

Back to top